Cardiology Medical News about PPAR-alpha

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death

3. The Job Market for 2008-2009: Compensation

4. Renal Artery Stenosis

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss
Cardiovascular Research, 07/20/09

Hafstad AD et al. – This study for the first time observed that in vivo administration of a synthetic PPAR–alpha ligand elevated FA oxidation, an effect that was also associated with decreased cardiac efficiency and reduced post–ischaemic functional recovery.

<< Previous
Enhanced Activity of Inositol-1,4,5-Trisphosphate Receptors in...

Next >>
Metformin decreases angiogenesis via NF-kB and Erk1/2/Erk5...

The Epoxygenases CYP2J2 Activates the Nuclear Receptor PPAR-alpha In Vitro and In Vivo
PLoS ONE - Cardiovascular Disorders, 10/20/09 Relevance Score: 84%

Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza
Evidence-based Complementary and Alternative Medicine, 10/05/09 Relevance Score: 82%